Ovid Therapeutics (OVID) Depreciation and Depletion (2016 - 2026)
Ovid Therapeutics (OVID) reported Depreciation and Depletion of $35000.0 for Q1 2026, down 59.77% on a YoY basis from $87000.0 in Q1 2025, and little changed quarter-over-quarter from $35000.0 in Q4 2025.
Ovid Therapeutics (OVID) Depreciation and Depletion (2016 - 2026) Analysis & Trends
Ovid Therapeutics has reported Depreciation and Depletion for 11 years, with the latest figure at $35000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation and Depletion fell 59.77% year-over-year to $35000.0; the trailing twelve-month figure through Mar 2026 stood at $148000.0 (down 61.66% YoY), and the FY2025 full-year result was $200000.0, down 50.0% from the prior year.
- Depreciation and Depletion for Q1 2026 stood at $35000.0, roughly flat from $35000.0 in the prior quarter.
- The five-year high for Depreciation and Depletion was $131632.0 in Q4 2022, with the low at $17000.0 in Q3 2025.
- Historically, Depreciation and Depletion has averaged $79598.4 across 5 years, with a median of $91000.0 in 2024.
- Annual changes were most pronounced in 2022 — Depreciation and Depletion surged 518.72% — and 2025, when it slumped 83.81%.
- Ovid Therapeutics' Depreciation and Depletion stood at $131632.0 in 2022, then slumped by 37.71% to $82000.0 in 2023, then increased by 10.98% to $91000.0 in 2024, then slumped by 61.54% to $35000.0 in 2025, then changed by 0.0% to $35000.0 in 2026.
- The last three Depreciation and Depletion figures came in at $35000.0 (Q1 2026), $35000.0 (Q4 2025), and $17000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ovid Therapeutics | 311.83 Mn | 156.31 Mn | - | 35,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35,000.00 |
| Mar 31, 2026 | 35,000.00 |
| Dec 31, 2025 | 35,000.00 |
| Dec 31, 2025 | 35,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Jun 30, 2025 | 61,000.00 |
| Jun 30, 2025 | 61,000.00 |
| Mar 31, 2025 | 87,000.00 |
| Mar 31, 2025 | 87,000.00 |
| Dec 31, 2024 | 91,000.00 |
| Dec 31, 2024 | 91,000.00 |
| Sep 30, 2024 | 105,000.00 |
| Sep 30, 2024 | 105,000.00 |
| Jun 30, 2024 | 103,000.00 |
| Jun 30, 2024 | 103,000.00 |
| Mar 31, 2024 | 101,000.00 |
| Mar 31, 2024 | 101,000.00 |
| Dec 31, 2023 | 82,000.00 |
| Dec 31, 2023 | 82,000.00 |